Tonix Pharmaceuticals Holding Corp.
TNXP
$13.29
$0.050.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -124.02M | -99.22M | -81.42M | -131.93M | -130.04M |
| Total Depreciation and Amortization | 1.93M | 1.93M | 2.48M | 2.90M | 3.42M |
| Total Amortization of Deferred Charges | 65.00K | 265.00K | -26.00K | 403.00K | 840.00K |
| Total Other Non-Cash Items | 11.81M | 11.03M | 10.20M | 67.36M | 59.08M |
| Change in Net Operating Assets | 10.38M | 11.17M | 3.93M | 1.33M | 5.78M |
| Cash from Operations | -99.84M | -74.82M | -64.84M | -59.93M | -60.93M |
| Capital Expenditure | -3.37M | -1.50M | -545.00K | -18.00K | -120.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.16M | -2.01M | -2.01M | -- | -- |
| Cash from Investing | -4.53M | -3.51M | -2.56M | -18.00K | -120.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.65M | -10.36M | -11.06M | -11.77M | -2.35M |
| Issuance of Common Stock | 246.69M | 265.89M | 213.89M | 211.94M | 147.46M |
| Repurchase of Common Stock | -13.76M | -5.95M | -5.95M | -3.05M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.75M | -9.05M | -8.29M | -12.51M | -10.24M |
| Cash from Financing | 214.53M | 240.54M | 188.59M | 184.62M | 134.87M |
| Foreign Exchange rate Adjustments | -31.00K | 7.00K | -6.00K | -1.00K | 4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.13M | 162.21M | 121.18M | 124.67M | 73.83M |